Cited by 175Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.

Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis

Open access

Meyer, Michelle L., Malek, Angela M., Wild, Robert A., Korytkowski, Mary T., Talbott, Evelyn O.·2012·Human Reproduction Update

DOI 10.1093/humupd/dmr046PMC PMC3383099

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disorder associated with cardiovascular disease (CVD) risk factors and metabolic disturbances. This systematic review and meta-analysis was conducted to determine whether carotid intima-media thickness (CIMT), a marker of subclinical atherosclerosis, is higher in women with PCOS compared with women without PCOS. METHODS: Primary articles reporting the mean CIMT in women with PCOS and controls were identified using Ovid MEDLINE, EMBASE and PUBMED. We performed a random-effects meta-analysis and created forest plots of the mean difference in CIMT and conducted tests for heterogeneity and publication bias. Studies were grouped by quality, defined by reporting reproducibility of CIMT and averaging both common carotid arteries versus one side for CIMT. RESULTS: From the 36 eligible full-text studies, 8 studies were included in the systematic review and 19 studies were included in the meta-analysis (total n= 1123 women with PCOS, n= 923 controls). The summary mean difference in CIMT among women with PCOS compared with controls was 0.072 mm [95% confidence interval (CI) 0.040, 0.105, P < 0.0001] for highest quality studies, 0.084 mm (95% CI 0.042, 0.126, P = 0.0001) for good quality studies, 0.041 (95% CI -0.038, 0.120, P = 0.310) for fair-quality studies and 0.045 (95% CI -0.020, 0.111, P = 0.173) for lower quality studies. CONCLUSIONS: Larger studies with a well-defined PCOS population using rigorous methodology may be required to draw a more robust conclusion. However, these results suggest women with PCOS are at a greater risk of premature atherosclerosis, which emphasizes the importance of screening and monitoring CVD risk factors in women with PCOS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/humupd/dmr046

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Assessing heterogeneity in meta-analysis: Q statistic or I² index?
Huedo-Medina, T. B., Sánchez-Meca, J., Marín-Martínez, F., & Botella, J. (2006) · Psychological Methods · doi:10.1037/1082-989x.11.2.193 · Cited by 4,256
Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis
Lorenz, M. W., Markus, H. S., Bots, M. L., Rosvall, M., & Sitzer, M. (2007) · Circulation · doi:10.1161/circulationaha.106.628875 · Cited by 2,977
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Impaired Glucose Tolerance, Type 2 Diabetes and Metabolic Syndrome in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108
Self-citation
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Self-citation
Carotid Intima-Media Thickening Indicates a Higher Vascular Risk Across a Wide Age Range
Lorenz, M., von Kegler, S., Steinmetz, H., Markus, H. S., & Sitzer, M. (2005) · Stroke · doi:10.1161/01.str.0000196964.24024.ea · Cited by 660
Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome
Legro, R. S., Kunselman, A. R., & Dunaif, A. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00948-2 · Cited by 622
Evidence for Association Between Polycystic Ovary Syndrome and Premature Carotid Atherosclerosis in Middle-Aged Women
Talbott, E. O., Guzick, D. S., Sutton-Tyrrell, K., McHugh-Pemu, K. P., Zborowski, J. V., Remsberg, K. E., & Kuller, L. H. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.11.2414 · Cited by 511
Self-citation
Polycystic ovary syndrome and cardiovascular disease: a premature association?
Legro, R. S. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0004 · Cited by 466
Prevalence and Predictors of Coronary Artery Calcification in Women with Polycystic Ovary Syndrome
Christian, R. C., Dumesic, D. A., Behrenbeck, T. R., Oberg, A. L., Sheedy, P. F., & Fitzpatrick, L. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030334 · Cited by 396
PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis
de Groot, P. C. M., Dekkers, O. M., Romijn, J. A., Dieben, S. W. M., & Helmerhorst, F. M. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr001 · Cited by 394
Increased C-Reactive Protein Levels in the Polycystic Ovary Syndrome: A Marker of Cardiovascular Disease
Boulman, N., Levy, Y., Leiba, R., Shachar, S. S., Linn, R., Zinder, O., & Blumenfeld, Z. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031096 · Cited by 332
Early Impairment of Endothelial Structure and Function in Young Normal-Weight Women with Polycystic Ovary Syndrome
Orio, F., Palomba, S., Cascella, T., Simone, B. D., Biase, S. D., Russo, T., Labella, D., Zullo, F., Lombardi, G., & Colao, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031867 · Cited by 330
Risk Factors for Progression of Common Carotid Atherosclerosis: The Atherosclerosis Risk in Communities Study, 1987-1998
Chambless, L. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.1.38 · Cited by 322
Metformin for the treatment of the polycystic ovary syndrome
Nestler, J. E. (2008) · New England Journal of Medicine · doi:10.1056/nejmct0707092 · Cited by 313
Endothelial Dysfunction in Young Women with Polycystic Ovary Syndrome: Relationship with Insulin Resistance and Low-Grade Chronic Inflammation
Tarkun, İ., ARSLAN, B., Cantürk, Z., Türemen, E., Şahı̇n, T., & Duman, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0751 · Cited by 298
An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data
Gavaghan, D. J., Moore, A. R., & McQuay, H. J. (2000) · Pain · doi:10.1016/s0304-3959(99)00302-4 · Cited by 276
Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters
Carmina, E., Chu, M. C., Longo, R. A., Rini, G. B., & Lobo, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2279 · Cited by 274
Evidence for an Association between Metabolic Cardiovascular Syndrome and Coronary and Aortic Calcification among Women with Polycystic Ovary Syndrome
Talbott, E. O., Zborowski, J. V., Rager, J. R., Boudreaux, M. Y., Edmundowicz, D., & Guzick, D. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032237 · Cited by 269
Self-citation
Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors
Espeland, M. A., O’Leary, D. H., Terry, J. G., Morgan, T., Evans, G., & Mudra, H. G. (2005) · Current Controlled Trials in Cardiovascular Medicine · doi:10.1186/1468-6708-6-3 · Cited by 220
Carotid atherosclerosis in women with polycystic ovary syndrome: Initial results from a case-control study
Guzick, D. S., Talbott, E. O., Sutton-Tyrrell, K., Herzog, H. C., Kuller, L. H., & Wolfson, S. K. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70665-8 · Cited by 210
Self-citation
Endothelial Dysfunction in PCOS: Role of Obesity and Adipose Hormones
Carmina, E., Orio, F., Palomba, S., Longo, R. A., Cascella, T., Colao, A. A. L., Lombardi, G., Rini, G. B., & Løbo, R. A. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.059 · Cited by 199
Young Obese Women with Polycystic Ovary Syndrome Have Evidence of Early Coronary Atherosclerosis
Juran, R., Kerchner, A., Maifeld, M., van Beek, E. J. R., Jagasia, D. H., & Dokras, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1343 · Cited by 194
Predictors of Endothelial Dysfunction in Young Women with Polycystic Ovary Syndrome
Kravariti, M., Naka, K. Κ., Kalantaridou, S., Kazakos, N., Katsouras, C. S., Makrigiannakis, A., Paraskevaidis, E. A., Chrousos, G. P., Tsatsoulis, A. A., & Michalis, L. K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0151 · Cited by 188
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome
Cascella, T., Palomba, S., de Sio, I., Manguso, F., Giallauria, F., Simone, B., Tafuri, D., Lombardi, G., Colao, A. M. L., & Orio, F. (2007) · Human Reproduction · doi:10.1093/humrep/dem356 · Cited by 184
Carotid Atherosclerosis in Premenopausal and Postmenopausal Women and Its Association With Risk Factors Measured After Menopause
Sutton‐Tyrrell, K., Lassila, H. C., Meilahn, E. N., Bunker, C. H., Matthews, K. A., & Kuller, L. H. (1998) · Stroke · doi:10.1161/01.str.29.6.1116 · Cited by 181
Risk Factors for Progression of Atherosclerosis Measured at Multiple Sites in the Arterial Tree
van der Meer, I. M., del Sol, A. I., Hak, A. E., Bots, M. L., Albert Hofman, D., & Witteman, J. C. M. (2003) · Stroke · doi:10.1161/01.str.0000088643.07108.19 · Cited by 172
Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome
Vryonidou, A., Papatheodorou, A., Tavridou, A., Terzi, T., Loi, V., Vatalas, I.-A., Batakis, N., Phenekos, C., & Dionyssiou-Asteriou, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2363 · Cited by 171
Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives
Cussons, A. J., Stuckey, B. G. A., & Watts, G. F. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.007 · Cited by 165
Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome
Vural, B., Çalışkan, E., Türköz, E., Kılıç, T., & Demırcı, A. (2005) · Human Reproduction · doi:10.1093/humrep/dei100 · Cited by 157
A dietary and exercise intervention slows menopause-associated progression of subclinical atherosclerosis as measured by intima-media thickness of the carotid arteries
Wildman, R. P., Schott, L. L., Brockwell, S. E., Kuller, L. H., & Sutton‐Tyrrell, K. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.078 · Cited by 157
Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome
Luque‐Ramírez, M., Mendieta-Azcona, C., Alvarez-Blasco, F., & Escobar-Morreale, H. F. (2007) · Human Reproduction · doi:10.1093/humrep/dem324 · Cited by 155
Intima-media thickness: indicator of cardiovascular risk and measure of the extent of atherosclerosis
Poredoš, P. (2004) · Vascular Medicine · doi:10.1191/1358863x04vm514ra · Cited by 149
Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women
Chae, S. J., Kim, J. J., Choi, Y. M., Hwang, K. R., Jee, B. C., Ku, S., Suh, C. S., Kim, S. H., Kim, J. G., & Moon, S. Y. (2008) · Human Reproduction · doi:10.1093/humrep/den239 · Cited by 127
Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome
Cascella, T., Palomba, S., Tauchmanovà, L., Manguso, F., Di Biase, S., Labella, D., Giallauria, F., Vigorito, C., Colao, A., Lombardi, G., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0399 · Cited by 120
Influence of lifestyle modification on atherosclerotic progression determined by ultrasonographic change in the common carotid intima-media thickness
Markus, R., Mack, W. J., Azen, S., & Hodis, H. N. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.4.1000 · Cited by 119
Asymmetrical Dimethylarginine, Inflammatory and Metabolic Parameters in Women with Polycystic Ovary Syndrome before and after Metformin Treatment
Heutling, D., Schulz, H., Nickel, I., Kleinstein, J., Kaltwaßer, P., Westphal, S., Mittermayer, F., Wolzt, M., Krzyżanowska, K., Randeva, H. S., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0842 · Cited by 117
Clinical Use of Carotid Intima-Media Thickness: Review of the Literature
Hurst, R. T., Ng, D. W. C., Kendall, C. M., & Khandheria, B. K. (2007) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2007.02.028 · Cited by 116
Predictors of Carotid Intima-Media Thickness Progression in Young Adults
Johnson, H. M., Douglas, P. S., Srinivasan, S. R., Bond, M. G., Tang, R., Li, S., Chen, W., Berenson, G. S., & Stein, J. H. (2007) · Stroke · doi:10.1161/01.str.0000258003.31194.0a · Cited by 113
Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome
Carmina, E., Bucchieri, S., Mansueto, P., Rini, G., Ferin, M., & Løbo, R. A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.03.007 · Cited by 103
Vascular Dysfunction and Metabolic Parameters in Polycystic Ovary Syndrome
Meyer, C., McGrath, B. P., Cameron, J., Kotsopoulos, D., & Teede, H. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1487 · Cited by 101
Cardiovascular Disease Risk Factors in Polycystic Ovary Syndrome
Dokras, A. (2008) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-992923 · Cited by 101
Intima-media thickness of elastic and muscular arteries of young women with polycystic ovaries
LAKHANI, K. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.04.007 · Cited by 88
High-Sensitivity C-Reactive Protein Is Not Associated With Carotid Intima-Media Progression
Lorenz, M., Karbstein, P., Markus, H. S., & Sitzer, M. (2007) · Stroke · doi:10.1161/strokeaha.106.476135 · Cited by 87
Prediction of Cardiovascular Morbidity and Mortality
Staub, D., Meyerhans, A., Bundi, B., Schmid, H. P., & Frauchiger, B. (2006) · Stroke · doi:10.1161/01.str.0000202589.47401.c6 · Cited by 85
Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?
Soares, G. M., Vieira, C. S., Martins, W. P., Franceschini, S. A., dos Reis, R. M., de Sá, M. F. S., & Ferriani, R. A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03506.x · Cited by 80
Correlates of increased lean muscle mass in women with polycystic ovary syndrome
Carmina, E., Guastella, E., Longo, R. A., Rini, G. B., & Løbo, R. A. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0398 · Cited by 79
Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors
Kaya, C., Pabuçcu, R., Berker, B., & Şatıroğlu, H. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.10.070 · Cited by 74
Not all women diagnosed with PCOS share the same cardiovascular risk profiles
Jovanovic, V. P., Carmina, E., & Løbo, R. A. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.04.021 · Cited by 68
Results of the primary outcome measure and clinical events from the asymptomatic carotid artery progression study
Probstfield, J. L., Margitić, S. E., Byington, R. P., Espeland, M. A., & Furberg, C. D. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80470-6 · Cited by 58
Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women?
Talbott, E. O. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s1452 · Cited by 58
Self-citation
Greater Arterial Stiffness in Polycystic Ovary Syndrome (PCOS) Is an Obesity- But Not a PCOS-Associated Phenomenon
Ketel, I. J. G., Stehouwer, C. D. A., Henry, R. M. A., Serné, E. H., Hompes, P. G. A., Homburg, R., Smulders, Y. M., & Lambalk, C. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0868 · Cited by 57
The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrom patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function
Arikan, S., Akay, H., Bahceci, M., Tuzcu, A., & Gokalp, D. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.057 · Cited by 49
Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction
Pepene, C. E., Ilie, I. R. P., Marian, I., & Duncea, I. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0720 · Cited by 49
Polycystic Ovarian Syndrome and the Risk of Cardiovascular Disease and Thrombosis
Mak, W., & Dokras, A. (2009) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0029-1242715 · Cited by 48
Oxidative Stress Markers in Young Patients with Polycystic Ovary Syndrome, The Relationship between Insulin Resistances
Karadeniz, M., Erdoğan, M., Tamsel, S., Zengi, A., Alper, G. E., Çağlayan, O., Saygılı, F., & Yılmaz, C. (2008) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-992154 · Cited by 44
Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population
Glueck, C. J., Morrison, J. A., Goldenberg, N., & Wang, P. (2009) · Metabolism · doi:10.1016/j.metabol.2009.02.005 · Cited by 44
Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome
Alexandraki, K., Protogerou, A. D., Papaioannou, T., Piperi, C., Mastorakos, G. P., Lekakis, J. P., Panidis, D., & Diamanti‐Kandarakis, E. (2006) · HORMONES · doi:10.14310/horm.2002.11176 · Cited by 43
Evaluation of endothelial function in women with polycystic ovary syndrome
Löwenstein, L., Damti, A., Pillar, G., Shott, S., & Blumenfeld, Z. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2007.02.011 · Cited by 39
Asymmetric dimethylarginine levels and carotid intima-media thickness in obese patients with polycystic ovary syndrome and their relationship to metabolic parameters
Pamuk, B. Ö., Torun, A. N., Kulaksızoğlu, M., Ertuğrul, D. T., Çiftçi, Ö., Kulaksızoğlu, S., Yıldırım, E., & Demirağ, N. G. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.10.073 · Cited by 35
Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome
Bux, F., Favale, S., Bhuva, A., Scicchitano, P., Vito, C., Lavopa, C., Pergola, G. D., & Loverro, G. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s5639 · Cited by 30
Thrombin-Activatable Fibrinolysis Inhibitor and Cardiovascular Risk Factors in Polycystic Ovary Syndrome
Erdoğan, M., Karadeniz, M., Alper, G. E., Tamsel, S., Uluer, H., Çağlayan, O., Saygılı, F., & Yılmaz, C. (2008) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-992118 · Cited by 24
The relationship of the interleukin‐6 −174 G>C gene polymorphism with cardiovascular risk factors in Turkish polycystic ovary syndrome patients
Erdoğan, M., Karadeniz, M., Berdelı, A., Tamsel, S., & Yılmaz, C. (2009) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2009.00867.x · Cited by 24
Low-grade chronic inflammation is not accompanied by structural arterial injury in polycystic ovary syndrome
Costa, L. O. B. F., dos Santos, M. P., de Oliveira, M., & Viana, A. D. O. R. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.04.005 · Cited by 22
Hemodynamic alterations and wall properties in large arteries of young, normotensive, and non-obese women with polycystic ovary syndrome
Trakakis, E., Balanika, A. P., Baltas, C. S., Loghis, C., Simeonidis, G., Vaggopoulos, V., Papakonstantinou, O., Gouliamos, A. D., Salamalekis, G., & Kassanos, D. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345639 · Cited by 21
Increased plasma thrombin-activatable fibrinolysis inhibitor levels in young obese women with polycystic ovary syndrome
Adalı, E., Yıldızhan, R., Kurdoğlu, M., Buğdaycı, G., Kolusarı, A., & Şahin, H. G. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.037 · Cited by 20
Correlation between serum lipid profile and carotid intima-media thickness in Polycystic Ovarian Syndrome
Saha, S., Sarkar, C., Biswas, S. C., & Karim, R. (2008) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-008-0059-6 · Cited by 15
Polycystic ovary syndrome and cardiovascular disease.
Loverro, G. (2004) · PubMed · Cited by 13
Detecting and describing heterogeneity in meta-analysis
Hardy, R. J., & Thompson, S. G. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980430)17:8

Research works printed but not linked: 2

Thompson, 2001, Continuous quality assessment programs can improve carotid duplex scan quality, J Vasc Technol, 25, 33
Zawadzki, 1992, Diagnostic criteria for polycystic ovary syndrome: towards a rationale approach, 377

Sorted by citations

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676
“A recent systematic review of the studies has conﬁrmed that C-IMT was thicker in women with PCOS in comparison with controls (204).”
Update on PCOS: consequences, challenges, and guiding treatment
Hoeger, K. M., Dokras, A., & Piltonen, T. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa839 · Cited by 610
Polycystic Ovary Syndrome and Cardiometabolic Risk: Opportunities for Cardiovascular Disease Prevention
Osibogun, O., Ogunmoroti, O., & Michos, E. D. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.08.010 · Cited by 423
Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences
Anagnostis, P. G., Tarlatzis, B. C., & Kauffman, R. P. (2017) · Metabolism · doi:10.1016/j.metabol.2017.09.016 · Cited by 445
Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus: A Scientific Statement From the American Heart Association
Regensteiner, J. G., Golden, S., Huebschmann, A. G., Barrett-Connor, E., Chang, A. Y., Chyun, D., Fox, C. S., Kim, C., Mehta, N., Reckelhoff, J. F., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000343 · Cited by 334

See all 175

Authors: Meyer, M. L., Malek, A. M., Wild, R. A., Korytkowski, M. T., & Talbott, E. O.
Affiliations: University of North Carolina at Chapel Hill (US)
University of Pittsburgh (US)
OU Health (US)
University of Pittsburgh Medical Center (US)
Corresponding author: Meyer, Michelle L.
ORCID: Meyer, Michelle L.
Malek, Angela M.
Wild, Robert A.
Korytkowski, Mary T.
Talbott, Evelyn O.
Venue: Human Reproduction Update
Publisher: Oxford University Press (OUP)
Published: 2011-11-22
Volume: 18
Issue: 2
Pages: 112-126
ISSN: 1355-4786 (ISSN-L)
1460-2369
DOI: 10.1093/humupd/dmr046
PMC: PMC3383099
OpenAlex: W2165694459
Cited by: 175
References: 79
Citations by year: 2026: 12 · 2025: 9 · 2024: 12 · 2023: 10 · 2022: 10 · 2021: 17 · 2020: 12 · 2019: 18 · 2018: 12 · 2017: 9 · 2016: 7 · 2015: 22 · 2014: 16 · 2013: 7 · 2012: 1
FWCI: 1.24
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Human Reproduction Update (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (T32 5T32HL007055-35, T32HL083825, T32HL007055)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: polycystic ovary syndrome, carotid intima-media thickness, subclinical atherosclerosis, cardiovascular risk, premature atherosclerosis, women's cardiovascular health, study quality heterogeneity
MeSH terms: Female, Humans, Polycystic Ovary Syndrome, Risk Factors, Atherosclerosis, Carotid Intima-Media Thickness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks